Much of a cell's DNA is transcriptionally silent because it is packaged in an inaccessible chromatin architecture. Chromatin remodeling enzymes play critical roles in preparing appropriate genes for transcription in the correct cell type by covalently modifying the flexible tails of histones that stick out of the nucleosomes and contact DNA. Altering chromatin architecture has major medical implications. Some cancers are at least in part due to epigenetic silencing of a tumor suppressor gene whose DNA sequence remains wild type. Likewise, several debilitating inherited diseases are caused by problems in imprinted genes where a wild type allele is present but silent. Finally, a major obstacle to successful gene therapy is the fact the even if exogenous DNA enters a cell, it often has no therapeutic effect because the gene is packaged in silent chromatin. The Drosophila MSL (male-specific lethal) dosage compensation complex provides an outstanding model system to study chromatin modifications because, 1) it acts on more than a thousand unrelated genes on the X chromosome, but not the autosomes, 2) its major MSL protein and roX RNA components have been identified, 3) the change in gene expression is very subtle, only two-fold, 4) the MSL complex is only required in males, allowing in vivo analysis of inactive partial/mutant complexes in females, and 5) the superb cytology of polytene chromosomes provides unequaled material to study target recognition in vivo. The MSL proteins and roX RNAs will be functionally dissected by characterizing mutants in vivo. The MSL complex is held as a model of epigenetic regulation because of its spectacular spreading behavior that can be directly visualized on polytene chromosomes. A new model to explain how cis spreading operates will be tested. New search methods will be developed to identify currently unknown noncoding RNAs. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM071538-01
Application #
6808753
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Carter, Anthony D
Project Start
2004-08-01
Project End
2008-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$289,713
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Lim, Chiat Koo; Kelley, Richard L (2013) The Drosophila over compensating males gene genetically inhibits dosage compensation in males. PLoS One 8:e60450
Prabhakaran, Mahalakshmi; Kelley, Richard L (2012) Mutations in the transcription elongation factor SPT5 disrupt a reporter for dosage compensation in Drosophila. PLoS Genet 8:e1003073
Lim, Chiat Koo; Kelley, Richard L (2012) Autoregulation of the Drosophila Noncoding roX1 RNA Gene. PLoS Genet 8:e1002564
Prabhakaran, Mahalakshmi; Kelley, Richard L (2010) A new strategy for isolating genes controlling dosage compensation in Drosophila using a simple epigenetic mosaic eye phenotype. BMC Biol 8:80
Kelley, Richard L; Lee, Ok-Kyung; Shim, Yoon-Kyung (2008) Transcription rate of noncoding roX1 RNA controls local spreading of the Drosophila MSL chromatin remodeling complex. Mech Dev 125:1009-19